Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-086410
Filing Date
2015-12-21
Accepted
2015-12-21 17:09:00
Documents
1
Period of Report
2015-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4018
  Complete submission text file 0001209191-15-086410.txt   5420
Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address
Turner Heather D (Reporting) CIK: 0001403571 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 151300115

Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)